HomeCYTO • CVE
add
Cytophage Technologies Ltd
Previous close
$0.20
Day range
$0.20 - $0.20
Year range
$0.13 - $0.45
Market cap
10.79M CAD
Avg Volume
57.62K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.15M | -28.37% |
Net income | -1.16M | 72.92% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -961.44K | 32.74% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 728.68K | -86.94% |
Total assets | 3.78M | -56.76% |
Total liabilities | 2.01M | -10.26% |
Total equity | 1.77M | — |
Shares outstanding | 53.94M | — |
Price to book | 6.67 | — |
Return on assets | -66.04% | — |
Return on capital | -74.51% | — |
Cash Flow
Net change in cash
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -1.16M | 72.92% |
Cash from operations | -728.01K | 65.46% |
Cash from investing | -3.14K | -100.04% |
Cash from financing | -74.62K | 47.59% |
Net change in cash | -805.77K | -114.55% |
Free cash flow | -329.52K | 76.59% |
About
Headquarters
Website
